ultra strength antacid
NDC 11673-933, Antacid, tablet, chewable, from Target Corporation.
- Product NDC
- 11673-933
- Status
- Listed
- Labeler
- Target Corporation
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M001
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/11673-933 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CALCIUM CARBONATE1000 mg/1
Pharmacologic classes
Blood Coagulation Factor [EPC]; Calcium [CS]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 11673-933-72 | 11673093372 | 72 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (11673-933-72) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 11673-933 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/11673-933 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 11673-933. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.